Os efeitos da colecalciferol (vitamina D) no sistema nervoso central em modelos experimentais/ The effects of collecalciferol (vitamin D) on the central nervous system in experimental models
Abstract
Keywords
Full Text:
PDF (Português (Brasil))References
ANDRADE, P. C. D. O. et al. Alimentação, fotoexposição e suplementação: influência nos níveis séricos de vitamina D. 2015.
BIKLE, D. D. Vitamin D metabolism, mechanism of action, and clinical applications. Chemistry & biology, v. 21, n. 3, p. 319-329, 2014.
CUI, X. et al. Vitamin D and the brain: key questions for future research. The Journal of steroid biochemistry and molecular biology, v. 148, p. 305-309, 2015.
CHIANG, Mathew; NATARAJAN, Radhika; FAN, Xiaoduo. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health, v. 19, n. 1, p. 6-9, 2016.
DELUCA, G. C. et al. the role of vitamin D in nervous system health and disease. Neuropathology and applied neurobiology, v. 39, n. 5, p. 458-484, 2013.
EYLES, D. et al. Intracellular distribution of the vitamin D receptor in the brain: comparison with classic target tissues and redistribution with development. Neuroscience, v. 268, p. 1-9, 2014.
EYLES, D. W. et al. Distribution of the vitamin D receptor and 1?-hydroxylase in human brain. Journal of chemical neuroanatomy, v. 29, n. 1, p. 21-30, 2005.
EVATT, Marian L. et al. Alta prevalência de hipovitaminose D em pacientes com doença de Parkinson precoce Arquivos de neurologia , v. 68, n. 3, p. 314-319, 2011.
ERICKSON, Kirk I. et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. Journal of Neuroscience, v. 30, n. 15, p. 5368-5375, 2010.
FELDMAN, D. et al. Genetic disorders of vitamin D synthesis and action. In: (Ed.). Genetics of Bone Biology and Skeletal Disease (Second Edition): Elsevier, 2017. p.735-759.
GARCION, E. et al. New clues about vitamin D functions in the nervous system. Trends in Endocrinology & Metabolism, v. 13, n. 3, p. 100-105, 2002.
HUANG, Ya-Ni et al. 1, 25-Dihydroxyvitamin D 3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. Journal of neuroinflammation, v. 12, n. 1, p. 147, 2015.
APA
KUBIS, A.M, PIWOWAR A. The new insight on the regulatory role of the vitamin D3 in metabolic pathways characteristic for cancerogenesis and neurodegenerative diseases Elsevier B.V. All rights reserved.2015
KUBIS, A. M.; PIWOWAR, A. The new insight on the regulatory role of the vitamin D3 in metabolic pathways characteristic for cancerogenesis and neurodegenerative diseases. Ageing research reviews, v. 24, p. 126-137, 2015.
LANDFIELD, Philip W.; CADWALLADER–NEAL, Lisa. Long-term treatment with calcitriol (1, 25 (OH) 2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiology of aging, v. 19, n. 5, p. 469-477, 1998.
MANN, M. C. et al. Vitamin D, the autonomic nervous system, and cardiovascular risk. Physiological Reports, v. 3, n. 4, 2015.
OUDSHOORN, Christian et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dementia and geriatric cognitive disorders, v. 25, n. 6, p. 539-543, 2008.
SHIVAKUMAR, Venkataram et al. Serum vitamin D and hippocampal gray matter volume in schizophrenia. Psychiatry Research: Neuroimaging, v. 233, n. 2, p. 175-179, 2015.
SONALI et al. Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug delivery, v. 23, n. 5, p. 1788-1798, 2016.
VALIPOUR, Ghazaleh; SANEEI, Parvane; ESMAILLZADEH, Ahmad. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. The Journal of Clinical Endocrinology & Metabolism, v. 99, n. 10, p. 3863-3872, 2014.
WANG, Jia-Yi et al. Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain research, v. 904, n. 1, p. 67-75, 2001.
DOI: https://doi.org/10.34119/bjhrv2n5-025
Refbacks
- There are currently no refbacks.